Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YK5U
|
|||
| Former ID |
DNC009897
|
|||
| Drug Name |
N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide
|
|||
| Synonyms |
N-(2,4-dichlorophenyl)-4-methyl-3-nitrobenzamide; CHEMBL551683; AC1Q2ECP; AC1LEFA7; Oprea1_406651; ZINC102894; BDBM50297547; AKOS002953737; MCULE-2443287207; ST011073
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H10Cl2N2O3
|
|||
| Canonical SMILES |
CC1=C(C=C(C=C1)C(=O)NC2=C(C=C(C=C2)Cl)Cl)[N+](=O)[O-]
|
|||
| InChI |
1S/C14H10Cl2N2O3/c1-8-2-3-9(6-13(8)18(20)21)14(19)17-12-5-4-10(15)7-11(12)16/h2-7H,1H3,(H,17,19)
|
|||
| InChIKey |
VNKILQNNNYOVJY-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Bacterial Fatty acid synthetase I (Bact inhA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening. Eur J Med Chem. 2009 Sep;44(9):3718-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.